Emory Receives $14 Million Federal Grant To Coordinate 50-Site Brain Attack Prevention Trial

March 31, 1999

An Aspirin A Day To Keep Stroke Away?

Doctors don't know how best to prevent stroke caused by clogged arteries in the brain -- a condition known as intracranial arterial stenosis.

To better evaluate two potential tactics for preventing this type of stroke in high-risk patients, the National Institute of Neurological Disorders and Stroke of the National Institutes of Health has funded the Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) study.

Emory University has been awarded more than $14 million from the institute to coordinate a five-year trial during which 806 patients will be evaluated at 50 sites in North America. The Clinical Coordinating Center will be based in the Department of Neurology at the Emory University School of Medicine, the Statistical Coordinating Center in the Department of Biostatistics at the Rollins School of Public Health of Emory University and the Pharmacy Coordinating Center at Emory University Hospital.

"This year we expect more than 700,000 Americans to experience a stroke, and of these, some 40,000 will sustain stroke caused by narrowing of the intracranial arteries," says WASID Principal Investigator Marc Chimowitz, M.B., ChB, associate professor and co-director of Emory Stroke Center in the Department of Neurology at the Emory University School of Medicine. "This type of stroke disproportionately affects minorities, including African-Americans, Asians and Hispanics.

"Our primary goal will be to compare the effectiveness of two different medications, warfarin or aspirin, for preventing stroke and vascular death in persons with intracranial stenosis," Dr. Chimowitz says.

Patients who have recently had a minor stroke or transient ischemic attack (TIA, or "mini stroke"), who are eligible to participate and sign an informed consent, will be randomized to receive either aspirin or warfarin, and will be evaluated by stroke experts at the WASID study site nearest them every four months for the duration of the study.

A stroke or "brain attack" occurs when blood circulation to the brain becomes interrupted. The most common type of stroke, ischemic stroke, occurs when an artery narrows or a blood clot blocks blood flow in an artery supplying the brain. A clot can form because of sluggish blood flow through a vessel narrowed by fatty, atherosclerotic deposits. Atherosclerosis in a major artery in the brain, intracranial stenosis, is a leading contributor to ischemic stroke and TIAs, particularly in minorities.

Stroke prevention in patients with intracranial stenosis typically involves reducing risk of blood clots through use of blood-thinning medications, including aspirin, Coumadin (warfarin), Plavix (clopidogrel), Ticlid (ticlopidine) and Persantine (dipyridamole). Doctors do not know which of these medications is most effective for prevention; WASID is intended to contribute valuable information to help make that determination.
-end-
Additional contact:
Kathi Ovnic, 404-727-9371 or covnic@emory.edu



Emory University Health Sciences Center

Related Stroke Articles from Brightsurf:

Stroke alarm clock may streamline and accelerate time-sensitive acute stroke care
An interactive, digital alarm clock may speed emergency stroke care, starting at hospital arrival and through each step of the time-sensitive treatment process.

Stroke patients with COVID-19 have increased inflammation, stroke severity and death
Stroke patients who also have COVID-19 showed increased systemic inflammation, a more serious stroke severity and a much higher rate of death, compared to stroke patients who did not have COVID-19, according a retrospective, observational, cross-sectional study of 60 ischemic stroke patients admitted to UAB Hospital between late March and early May 2020.

'Time is vision' after a stroke
University of Rochester researchers studied stroke patients who experienced vision loss and found that the patients retained some visual abilities immediately after the stroke but these abilities diminished gradually and eventually disappeared permanently after approximately six months.

More stroke awareness, better eating habits may help reduce stroke risk for young adult African-Americans
Young African-Americans are experiencing higher rates of stroke because of health conditions such as high blood pressure, diabetes and obesity, yet their perception of their stroke risk is low.

How to help patients recover after a stroke
The existing approach to brain stimulation for rehabilitation after a stroke does not take into account the diversity of lesions and the individual characteristics of patients' brains.

Kids with headache after stroke might be at risk for another stroke
A new study has found a high incidence of headaches in pediatric stroke survivors and identified a possible association between post-stroke headache and stroke recurrence.

High stroke impact in low- and middle-income countries examined at 11th World Stroke Congress
Less wealthy countries struggle to meet greater need with far fewer resources.

Marijuana use might lead to higher risk of stroke, World Stroke Congress to be told
A five-year study of hospital statistics from the United States shows that the incidence of stroke has risen steadily among marijuana users even though the overall rate of stroke remained constant over the same period.

We need to talk about sexuality after stroke
Stroke survivors and their partners are not adequately supported to deal with changes to their relationships, self-identity, gender roles and intimacy following stroke, according to new research from the University of Sydney.

Standardized stroke protocol can ensure ELVO stroke patients are treated within 60 minutes
A new study shows that developing a standardized stroke protocol of having neurointerventional teams meet suspected emergent large vessel occlusion (ELVO) stroke patients upon their arrival at the hospital achieves a median door-to-recanalization time of less than 60 minutes.

Read More: Stroke News and Stroke Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.